Canada: Competition Bureau Releases Guidelines In Respect Of Settlements Under The PM(NOC) Regulations

On March 31, 2016, the Competition Bureau released its updated Intellectual Property Enforcement Guidelines (the "IPEGs").  The updated IPEGs replace the version dated September 18, 2014.  Only Part 7 of the IPEGs ("Application of Competition Law to IP") has been substantively changed. Of particular interest to the pharmaceutical industry are the sections of the IPEGs related to the application of competition law to settlement agreements under the Patented Medicines (Notice of Compliance) Regulations ("PM(NOC) Regulations") and to "soft" product switches. In a separate article, we address the Bureau's views with respect to the conduct of patent assertion entities ("PAEs") and conduct concerning standard essential patents ("SEPs").

Settlements under the PM(NOC) Regulations

Section 7.3 of the IPEGs is a new section advising how the Bureau approaches settlement agreements under the PM(NOC) Regulations.  Generally speaking, the IPEGs indicate that a settlement agreement wherein the generic is permitted to launch before or upon patent expiry will not be reviewed by the Bureau.  However, where the agreement also encompasses a payment made by the innovator to the generic, the Bureau may review the agreement under the civil provisions of the Competition Act (the "Act") dealing with anti-competitive agreements between competitors (section 90.1)1 and, possibly, abuse of dominance (section 79). 

Both sections 90.1 and 79 of the Act require the Bureau to establish that a settlement has had, is having or is likely to have the effect of substantially preventing or lessening competition in a market.  Thus, the Bureau determines what would have likely occurred "but for" the settlement agreement and assesses whether the payment was so large as to significantly affect a generic's entry into the market.  In doing so, the Bureau will consider such factors as (a) the fair market value of any goods or services provided by the generic; (b) the magnitude of the innovator's exposure to section 8 damages under the PM(NOC) Regulations; and (c) the innovator's expected litigation costs (in current and future related proceedings) in the absence of the settlement agreement.

With respect to investigations under section 90.1 of the Act, if the Bureau finds that the settlement agreement does or is likely to substantially prevent or lessen competition, the Bureau will consider whether the agreement generates any countervailing efficiencies.   For example, if the restriction on competition led to long-term increases in product selection, quality, output and productivity, the Bureau may not seek a remedy under section 90.1.2

With respect to investigations under section 79 of the Act, the IPEGs indicate that the Bureau would consider possible business justifications (pro-competitive rationales for the conduct) in its determination of whether the settlement was anti-competitive.

If the Bureau considers that there has been a violation of section 90.1 or 79 of the Act, it may seek remedies under one or both of these provisions, which may include prohibition orders and, in the case of abuse of dominance, administrative monetary penalties of up to $10 million for a first offence and up to $15 million for subsequent offences.

In the IPEGs, the Bureau clarifies that it will typically not review agreements pursuant to the criminal provisions of the Act (section 45) unless the settlement clearly extends beyond the exclusionary potential of the patent or is a "sham". The IPEGs provide some specific examples of the types of agreements that might attract such scrutiny: (a) where the generic is restricted from entry into the market beyond the term of the patent; (b) where the agreement restricts competition in respect of products not at issue in the PM(NOC) proceeding; or (c) where the parties recognize that the patent is invalid and/or not infringed.

Product Switches

In the 2014 version of the IPEGs, the Bureau had identified that "hard switches" of products done for the primary purpose of retaining the innovator's market strength past patent expiry could be viewed as something more than just the exercise of IP rights and might therefore attract scrutiny under section 79 (abuse of dominance) of the Act.  Specifically, the Bureau outlined a scenario where an innovator has a successful product ("Product A") which is set to lose patent protection, and the innovator introduces a slightly different form of that product ("Product B") which remains under patent protection for several more years.  In this hypothetical scenario, the innovator then removes Product A from the market prior to patent expiry, which causes health care professionals to switch to Product B.  Since any generic that would have been competitive with Product A would not be interchangeable with Product B, the generic's entry upon patent expiry of Product A may be impeded. 

In the updated IPEGs, the Bureau notes that "soft" product switches would likely not raise any issue under the Act.  The IPEGs describe "soft" switches as similar to the scenario above, but instead of removing Product A from the market, the company simply stops promoting Product A to health care professionals.

A copy of the updated IPEGs are available here.


1.The IPEGs advise that the Bureau's approach to assessing such collaborations is reflected in the Competitor Collaboration Guidelines.

2. The Bureau's approach to the analysis of efficiencies is described in Part 12 of the Merger Enforcement Guidelines.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Events from this Firm
8 Nov 2016, Seminar, Ottawa, Canada

The prospect of an internal investigation raises many thorny issues. This presentation will canvass some of the potential triggering events, and discuss how to structure an investigation, retain forensic assistance and manage the inevitable ethical issues that will arise.

22 Nov 2016, Seminar, Ottawa, Canada

From the boardroom to the shop floor, effective organizations recognize the value of having a diverse workplace. This presentation will explore effective strategies to promote diversity, defeat bias and encourage a broader community outlook.

7 Dec 2016, Seminar, Ottawa, Canada

Staying local but going global presents its challenges. Gowling WLG lawyers offer an international roundtable on doing business in the U.K., France, Germany, China and Russia. This three-hour session will videoconference in lawyers from around the world to discuss business and intellectual property hurdles.

In association with
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.